Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in AGEN — Agenus Inc

CIK 1387508 NEW YORK, NY

Position in AGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$60,468
+$10,702 QoQ
Shares Held
19,761
+32.6% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 103 holders
Holding Since
Jun 2020
8 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AGEN Over Time

Shares Held

Position Value (USD)

Derivatives in AGEN

reported options exposure · as of Sep 30, 2020
CallValue
$1,199
CallShares
15
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $41,687,806 across 71 Biotechnology names. AGEN ranks #61 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AGEN

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,468 19,761
2026-03-31 $49,766 14,900
2025-12-31 $45,530 14,500
2023-12-31 $22,309 26,879
2023-03-31 $16,105 10,596
2021-12-31 $43,717 13,577
2020-09-30 $1,199 300
2020-06-30 $1,178 300